4.
Adverse events of the two groups
| Adverse events | CIK group
(n = 147) |
Control group
(n = 147) |
P |
| Bone marrow suppression | 0.222 | ||
| 0 | 98 | 84 | |
| I | 20 | 35 | |
| II | 18 | 16 | |
| III | 8 | 10 | |
| IV | 3 | 2 | |
| Fever | 0.491 | ||
| 0 | 118 | 112 | |
| I | 28 | 32 | |
| II | 1 | 3 | |
| III | 0 | 0 | |
| IV | 0 | 0 | |
| Nausea and vomiting | 0.545 | ||
| 0 | 98 | 94 | |
| I | 18 | 13 | |
| II | 23 | 31 | |
| III | 8 | 9 | |
| IV | 0 | 0 | |
| Liver dysfunction | 0.641 | ||
| 0 | 120 | 117 | |
| I | 17 | 21 | |
| II | 10 | 8 | |
| III | 0 | 1 | |
| IV | 0 | 0 | |
| Kidney dysfunction | 0.415 | ||
| 0 | 137 | 134 | |
| I | 9 | 13 | |
| II | 1 | 0 | |
| III | 0 | 0 | |
| IV | 0 | 0 | |
| Peripheral nerve toxicity | 0.542 | ||
| 0 | 132 | 126 | |
| I | 10 | 13 | |
| II | 5 | 8 | |
| III | 0 | 0 | |
| IV | 0 | 0 | |